BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32704164)

  • 21. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
    Woodring J; Pastore R; Brink A; Ishikawa N; Takashima Y; Tohme RA
    MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(8):195-200. PubMed ID: 30817746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop].
    Zimmermann R; Külper-Schiek W; Steffen G; Gillesberg Lassen S; Bremer V; Dudareva S;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Jan; 64(1):77-90. PubMed ID: 33326051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How far are we from viral hepatitis elimination service coverage targets?
    Hutin YJ; Bulterys M; Hirnschall GO
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25050. PubMed ID: 29633520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].
    Liu J; Liu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):605-609. PubMed ID: 31238605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards the eradication of hepatitis B in Taiwan.
    Wait S; Chen DS
    Kaohsiung J Med Sci; 2012 Jan; 28(1):1-9. PubMed ID: 22226055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.
    Al Awaidy ST; Ezzikouri S
    J Infect Public Health; 2020 Feb; 13(2):221-227. PubMed ID: 31445879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress on global hepatitis elimination targets.
    Waheed Y
    World J Gastroenterol; 2021 Dec; 27(47):8199-8200. PubMed ID: 35068864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in viral hepatitis.
    Friedman LS; Dienstag JL
    Dis Mon; 1986 Jun; 32(6):313-85. PubMed ID: 3009113
    [No Abstract]   [Full Text] [Related]  

  • 29. Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943-2020).
    Yang HC; Kao JH
    J Formos Med Assoc; 2020 Aug; 119(8):1247-1248. PubMed ID: 32654867
    [No Abstract]   [Full Text] [Related]  

  • 30. Viral hepatitis A, B, and C: grown-up issues.
    Sharapov UM; Hu DJ
    Adolesc Med State Art Rev; 2010 Aug; 21(2):265-86, ix. PubMed ID: 21047029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Towards eliminating viral hepatitis": Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination.
    Lancaster K; Rhodes T; Rance J
    Int J Drug Policy; 2020 Jun; 80():102419. PubMed ID: 30975593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mobilising a global response to hepatitis: Lessons learned from the HIV movement.
    Taaffe J; Wilson D
    Glob Public Health; 2018 Apr; 13(4):473-488. PubMed ID: 27748158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public Health Approaches Toward Eliminating Hepatitis C Virus in Rhode Island.
    Murphy M; Howe K; Marak T; Bertrand T; Maynard M; Ndoye CD; Joseph R; Fingerut J; Chan PA
    R I Med J (2013); 2020 Jun; 103(5):22-25. PubMed ID: 32481775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?
    Amponsah-Dacosta E
    World J Gastroenterol; 2021 Sep; 27(36):6025-6038. PubMed ID: 34629817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
    Schröeder SE; Pedrana A; Scott N; Wilson D; Kuschel C; Aufegger L; Atun R; Baptista-Leite R; Butsashvili M; El-Sayed M; Getahun A; Hamid S; Hammad R; 't Hoen E; Hutchinson SJ; Lazarus JV; Lesi O; Li W; Binti Mohamed R; Olafsson S; Peck R; Sohn AH; Sonderup M; Spearman CW; Swan T; Thursz M; Walker T; Hellard M; Howell J
    Liver Int; 2019 Oct; 39(10):1818-1836. PubMed ID: 31433902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
    Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
    S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B associated with an alternative therapy centre: look back is extended to include hepatitis C.
    Commun Dis Rep CDR Wkly; 1998 Jun; 8(23):201. PubMed ID: 9658233
    [No Abstract]   [Full Text] [Related]  

  • 38. Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection--sub-Saharan Africa, 2000-2011.
    Apata IW; Averhoff F; Pitman J; Bjork A; Yu J; Amin NA; Dhingra N; Kolwaite A; Marfin A;
    MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(29):613-9. PubMed ID: 25055184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WORLD HEPATITIS SUMMIT HARNESSES GLOBAL MOMENTUM TO ELIMINATE VIRAL HEPATITIS.
    Cent Eur J Public Health; 2015 Sep; 23(3):272. PubMed ID: 26618210
    [No Abstract]   [Full Text] [Related]  

  • 40. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.